Literature DB >> 22648911

Aortic pseudoaneurysm: a rare complication of mediastinoscopy.

Andrea Billè1, Charlotte Longman, John Pilling.   

Abstract

Mediastinoscopy still represents the gold standard in mediastinal lymph node staging in patients with lung cancer. It is an invasive procedure, where complications are unusual. This case report shows an uncommon complication after mediastinoscopy: pseudoaneurysm of the aortic arch and its minimally invasive endovascular stenting treatment in order to facilitate the recovery and to allow minimal delay to oncological treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22648911     DOI: 10.1007/s11748-012-0116-1

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  5 in total

Review 1.  The future in diagnosis and staging of lung cancer: surgical techniques.

Authors:  P A Catarino; P Goldstraw
Journal:  Respiration       Date:  2006       Impact factor: 3.580

2.  Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.

Authors:  Anthony Lemaire; Ivana Nikolic; Thomas Petersen; Jack C Haney; Eric M Toloza; David H Harpole; Thomas A D'Amico; William R Burfeind
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

3.  Traumatic pseudoaneurysm of the brachiocephalic artery following medianoscopy: initial endovascular repair followed by open surgery--a case report.

Authors:  Matthias Biebl; B Neuhauser; R Perkmann; T Tauscher; P Waldenberger; G Fraedrich
Journal:  Am Surg       Date:  2003-06       Impact factor: 0.688

4.  Endovascular treatment of a brachiocephalic artery pseudoaneurysm secondary to biopsy at mediastinoscopy.

Authors:  Irfan Ahmed; Konstantinos Katsanos; Farhan Ahmad; Renato Dourado; Oliver Lyons; John Reidy
Journal:  Cardiovasc Intervent Radiol       Date:  2008-10-07       Impact factor: 2.740

Review 5.  Initial surgical staging of lung cancer.

Authors:  Bernward Passlick
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.